Christopher K Daugherty
Overview
Explore the profile of Christopher K Daugherty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1447
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hlubocky F, Cella D, Daugherty C
JCO Oncol Pract
. 2025 Jan;
21(1):52-56.
PMID: 39793557
No abstract available.
2.
Roloff G, Wen F, Ramsland A, Artz A, Kosuri S, Stock W, et al.
Haematologica
. 2023 Jan;
108(8):2234-2239.
PMID: 36655425
No abstract available.
3.
Hlubocky F, Daugherty C, Peppercorn J, Young K, Wroblewski K, Yamada S, et al.
JCO Clin Cancer Inform
. 2022 Aug;
6:e2200035.
PMID: 35985004
Purpose: Novel distress screening approaches using electronic patient-reported outcome (ePRO) measurements are critical for the provision of comprehensive quality community cancer care. Using an ePRO platform, the prevalence of psychosocial...
4.
Hlubocky F, Sher T, Cella D, Wroblewski K, Peppercorn J, Daugherty C
JCO Oncol Pract
. 2021 Feb;
17(2):e101-e110.
PMID: 33567241
Purpose: Advanced cancer patients (ACP) hope to receive significant therapeutic benefit from phase I trials despite terminal disease and presumed symptom burdens. We examined associations between symptom burdens and expectations...
5.
Hlubocky F, Symington B, McFarland D, Gallagher C, Dragnev K, Burke J, et al.
JCO Oncol Pract
. 2021 Feb;
17(7):365-374.
PMID: 33555934
No abstract available.
6.
Hantel A, Hlubocky F, Siegler M, Daugherty C
JCO Oncol Pract
. 2020 May;
16(10):e1098-e1111.
PMID: 32469685
Purpose: Medication shortages in US hospitals are ongoing, widespread, and frequently involve antineoplastic and supportive medications used in cancer care. The ways shortages are managed and the ways provider-patient communication...
7.
Hantel A, Egan A, Nguyen T, DeMartino E, Hlubocky F, Bastow S, et al.
J Grad Med Educ
. 2020 Feb;
12(1):38-43.
PMID: 32089792
Background: Medication shortages prevent patients from receiving optimal care. Despite the frequency with which medical trainees care for inpatients, no assessment of their experiences in medication shortage management has been...
8.
9.
Garrett S, Matthews T, Abramson C, Koenig C, Hlubocky F, Daugherty C, et al.
JCO Oncol Pract
. 2019 Oct;
16(1):e56-e63.
PMID: 31603726
Purpose: Patients with advanced cancer and oncologists deliberate about early-phase (EP) trials as they consider whether to pursue EP trial enrollment. We have limited information about those deliberations and how...
10.
Hantel A, Siegler M, Hlubocky F, Colgan K, Daugherty C
JAMA Intern Med
. 2019 Mar;
179(5):710-711.
PMID: 30907925
No abstract available.